Raymond C. Meadows II, 52, and Helen Crutcher Meadows, 49, founders of Lifehouse Inc., a faith-based substance abuse recovery nonprofit based in West Virginia, face federal conspiracy to commit wire fraud charges announced June 26 by U.S. Attorney Moore Capito for the Southern District of West Virginia [1]. The charges were filed as part of a national health care fraud enforcement action coordinated by the Department of Justice [1].
Prosecutors allege the Meadowses submitted falsified timesheets to a drug testing laboratory, billing 32 hours of overtime per week for extended periods and claiming reimbursement for hours during which both defendants were on out-of-state vacations [1]. Those submissions, prosecutors contend, resulted in fraudulent payments drawn from federal and state health care programs [1]. Wire fraud conspiracy under 18 U.S.C. § 1349 carries a statutory maximum of 20 years' imprisonment per count. Lifehouse Inc. operated under a faith-based recovery model serving individuals in a state that has consistently reported among the nation's highest rates of overdose mortality.
The charges reflect a prosecutorial focus that extends beyond licensed clinical providers to encompass nonprofit entities that participate in the addiction recovery infrastructure through ancillary service contracts, such as drug testing arrangements, which funnel federal and state reimbursement dollars outside direct patient-care settings. HHS Office of Inspector General and the FBI are listed among the investigating agencies, consistent with joint-agency coordination typical of national health care fraud takedowns [1]. The Southern District of West Virginia has pursued health care fraud matters at elevated volume given the region's sustained exposure to opioid-related program spending.
The case is at the charging stage, and no plea has been entered. If convicted, the Meadowses face substantial custodial exposure alongside potential restitution to the defrauded federal and state programs. The national sweep of which this prosecution forms a part signals continued DOJ prioritization of fraud within the addiction treatment and recovery sector, an area that expanded rapidly in program funding during and after the peak opioid crisis years and has drawn sustained scrutiny from federal investigators.